keyword
https://read.qxmd.com/read/38444927/a-case-of-rapidly-growing-tricuspid-valve-papillary-fibroelastoma-presenting-with-syncope
#21
Ibrahim Kamel, Harold Dietzius, Toni Magee, Sadaf Esteghamati
Cardio-oncology, at the intersection of cardiovascular diseases, oncological conditions, and treatments, presents unique challenges in medical care. This abstract highlights a case involving a 60-year-old male presenting with syncope at work; the workup revealed a rapidly growing tricuspid valve papillary fibroelastoma (PFE), emphasizing diagnostic approaches, management strategies, and clinical implications. The diagnostic investigation, including blood cultures, transthoracic echocardiogram, transesophageal echocardiogram, and cardiac MRI, confirmed the diagnosis of tricuspid valve PFE...
March 2024: Curēus
https://read.qxmd.com/read/38441886/atrial-secondary-tricuspid-regurgitation-pathophysiology-definition-diagnosis-and-treatment
#22
JOURNAL ARTICLE
Denisa Muraru, Luigi P Badano, Rebecca T Hahn, Roberto M Lang, Victoria Delgado, Nina C Wunderlich, Erwan Donal, Maurizio Taramasso, Alison Duncan, Philipp Lurz, Tom De Potter, José L Zamorano Gómez, Jeroen J Bax, Ralph Stephan von Bardeleben, Maurice Enriquez-Sarano, Francesco Maisano, Fabien Praz, Marta Sitges
Atrial secondary tricuspid regurgitation (A-STR) is a distinct phenotype of secondary tricuspid regurgitation with predominant dilation of the right atrium and normal right and left ventricular function. Atrial secondary tricuspid regurgitation occurs most commonly in elderly women with atrial fibrillation and in heart failure with preserved ejection fraction in sinus rhythm. In A-STR, the main mechanism of leaflet malcoaptation is related to the presence of a significant dilation of the tricuspid annulus secondary to right atrial enlargement...
March 5, 2024: European Heart Journal
https://read.qxmd.com/read/38439997/cor-triatriatum-dexter-with-a-sinus-venosus-atrial-septal-defect-in-a-50-year-old-woman-a-case-report
#23
Hasan Kazma, Malak Fakih, Ali Raad, Aalaa Saleh, Malek Mohammed
The diagnosis of atrial septal defect (ASD) may be delayed until adulthood or even later in life as it is a well-tolerated congenital heart disease. If patients are not examined and investigated well in childhood, the diagnosis may be delayed until later in adulthood when patients present with palpitations and sometimes dyspnea due to the right chambers dilatation from right ventricular volume overload. In this report, we present a case of a 50-year-old female patient with symptoms of heart failure and atrial fibrillation who was found to have dilated right cardiac chambers, dilated pulmonary artery, severe tricuspid regurgitation, pulmonary hypertension, and a pulmonary-to-systemic flow ratio (Qp/Qs) of more than 1...
February 2024: Curēus
https://read.qxmd.com/read/38437953/effects-of-tricuspid-transcatheter-edge-to-edge-repair-on-tricuspid-annulus-diameter-data-from-the-trivalve-registry
#24
JOURNAL ARTICLE
Giulio Russo, Rebecca T Hahn, Hannes Alessandrini, Martin Andreas, Luigi P Badano, Daniel Braun, Kim A Connelly, Paolo Denti, Rodrigo Estevez-Loureiro, Neil Fam, Mara Gavazzoni, Joerg Hausleiter, Dominique Himbert, Daniel Kalbacher, Azeem Latib, Edith Lubos, Sebastian Ludwig, Philipp Lurz, Vanessa Monivas, Georg Nickenig, Daniela Pedicino, Giovanni Pedrazzini, Alberto Pozzoli, Fabien Praz, Joseph Rodes-Cabau, Karl-Philipp Rommel, Joachim Schofer, Horst Sievert, Gilbert Tang, Holger Thiele, Matthias Unterhuber, Ralph Stephan von Bardeleben, John Webb, Stephan Windecker, Martin Leon, Francesco Maisano, Maurizio Taramasso
AIMS: T-TEER is an effective therapy for the treatment of tricuspid regurgitation (TR). However, the effects of leaflets clipping on tricuspid valve annulus (TA) have not been investigated in detail. The aim of this study is to investigate the effects of tricuspid transcatheter edge-to-edge repair (T-TEER) on TA diameter. METHODS AND RESULTS: The TriValve registry (Transcatheter Tricuspid Valve Therapies, NCT03416166) collected 556 patients from 22 European and North American centres undergoing transcatheter tricuspid valve interventions from 2016 to 2022...
March 2, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38436690/-conservative-treatment-of-valvular-heart-disease-in-adults
#25
REVIEW
Johannes Kirchner, Tanja K Rudolph
Currently, there is no specific medication approved for the treatment of valvular heart disease per se. Except for secondary mitral valve insufficiency and tricuspid valve insufficiency in pulmonary hypertension, drug therapy for higher-grade valvular heart disease is limited to diuretic therapy for symptom control. Conservative therapy for comorbidities and potential heart failure can be beneficial regardless of the specific valve lesion. In cases of aortic valve stenosis or insufficiency, controlling arterial hypertension is important...
March 4, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38436368/early-outcomes-of-transapical-mitral-valve-implantation-versus-surgical-replacement-in-matched-elderly-patients-at-intermediate-surgical-risk
#26
JOURNAL ARTICLE
Johannes A Ziegelmueller, Melchior Burri, Andreas Stein, Peter Tassani-Prell, Markus Krane, Rüdiger Lange, Hendrik Ruge
BACKGROUND: Data comparing transcatheter mitral valve implantation (TMVI) with surgical mitral valve replacement (SMVR) are lacking. AIMS: This study sought to compare the 30-day Valve Academic Research Consortium (VARC)-3 device success of TMVI with that of SMVR. METHODS: Matching protocol combined exact matching (sex, atrial fibrillation, previous surgical aortic valve replacement [SAVR] or coronary artery bypass grafting [CABG]), coarsened exact matching (age) and propensity score matching (body mass index, mitral valve pathology and concomitant tricuspid regurgitation)...
March 4, 2024: EuroIntervention
https://read.qxmd.com/read/38435890/a-case-of-right-sided-infective-endocarditis-requiring-angiovac-debulking
#27
Danielle Pawlichuk, Micah Pippin
Infective endocarditis is an uncommon but consequential disease process that occurs after damage to the cardiac endothelium. Management depends on location and infection severity, but it can typically be treated with intravenous antibiotics. Still, in more complex presentations, surgical intervention may be warranted. Here, we examine a case of right-sided infective endocarditis affecting the tricuspid valve in a patient with a history of intravenous drug use. The purpose of this paper is to examine a case of right-sided endocarditis refractory to intravenous antibiotics, resulting in the need for an alternative treatment modality using AngioVAC debulking...
January 2024: Curēus
https://read.qxmd.com/read/38434934/a-case-series-of-minimally-invasive-robotic-assisted-resection-of-cardiac-papillary-fibroelastoma-the-mayo-clinic-experience
#28
JOURNAL ARTICLE
Ali Ahmad, Edward A El-Am, Piotr Mazur, Elias Akiki, Ahmed A Sorour, Reto D Kurmann, Kyle W Klarich, Arman Arghami, Phillip G Rowse, Richard C Daly, Joseph A Dearani
Papillary fibroelastomas (PFEs) are small, slowly growing benign cardiac tumors with clinically significant risk of embolization. Surgical excision is the definitive treatment of symptomatic PFE and is conventionally performed through a median sternotomy. In this study, we report a series of 12 patients, who underwent robotic-assisted PFE removal at the Mayo Clinic. PFE involved the mitral valve, left atrium, and tricuspid valve. No major complications occurred after the procedure, and most patients were discharged 4 days after the surgery...
April 2024: Mayo Clinic Proceedings. Innovations, Quality & Outcomes
https://read.qxmd.com/read/38432770/transcatheter-treatment-of-mitral-valve-regurgitation-in-the-setting-of-concomitant-coronary-or-multivalvular-heart-disease-a-focused-review
#29
REVIEW
Jay Ramsay, Yicheng Tang, Jin Kyung Kim, Antonio H Frangieh
Treatment for mixed valve disease has historically been limited, often surgery being the only option. With the recent advancement of transcatheter therapies, percutaneous approaches are quickly becoming viable therapeutic considerations in inoperable or high-risk patients, also offering the option for a staged or same-session treatment. Guidelines are primarily focused on single-valve disease. However, patients often present with multiple pathologies. This review summarizes the data and literature on transcatheter treatment of patients with mitral regurgitation who concomitantly have aortic stenosis or regurgitation, tricuspid regurgitation, or ischemic cardiomyopathy...
April 2024: Interventional Cardiology Clinics
https://read.qxmd.com/read/38432474/deformation-in-transcatheter-heart-valves-clinical-implications-and-considerations
#30
REVIEW
Miho Fukui, João L Cavalcante, Vinayak N Bapat
Transcatheter aortic valve replacement (TAVR) has emerged as a preferred treatment modality for aortic stenosis, marking a significant advancement in cardiac interventions. Transcatheter heart valves (THVs) have also received approval for treating failed bioprosthetic valves and rings across aortic, mitral, tricuspid, and pulmonic positions. Unlike surgically implanted valves, which are sewn into the annulus, THVs are anchored through relative oversizing. Although THVs are designed to function optimally in a fully expanded state, they exhibit a certain degree of tolerance to underexpansion...
March 1, 2024: Journal of Cardiology
https://read.qxmd.com/read/38432337/transcatheter-intervention-for-inoperable-tricuspid-surgical-prosthesis-dysfunction-minimally-invasive-approach-to-mitigate-heart-failure
#31
JOURNAL ARTICLE
Piotr Nikodem Rudziński, Jan Henzel, Adam Witkowski, Maciej Dąbrowski, Zenon Huczek, Wojciech Wojakowski, Radosław Targoński, Dariusz Jagielak, Paweł Kralisz, Marcin Demkow
No abstract text is available yet for this article.
March 1, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38432332/etiologies-and-impact-of-exclusion-rates-for-transcatheter-mitral-and-tricuspid-valve-structural-heart-clinical-trials-at-a-high-volume-quaternary-care-hospital
#32
JOURNAL ARTICLE
Lu Chen, Lin Wang, George Petrossian, Newell Robinson, William Chung, Matthew Henry, Dennis Mihalatos, Ruqiyya Bano, Jonathan Weber, Jaffar Khan, David J Cohen, Andrew Berke, Ziad Ali, Omar K Khalique
There are various devices under clinical investigation for transcatheter mitral valve intervention (TMVI) and tricuspid valve intervention (TTVI), but exclusion rates remain high. We aim to investigate exclusion rates for transcatheter mitral valve repair (TMVr), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve repair (TTVr) and transcatheter tricuspid valve replacement (TTVR). There were a total of 129 patients who were referred to St. Francis Hospital & Heart Center valve clinic and completed screening between January 2021 and July 2022...
March 1, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38430242/concomitant-interventions-in-mitral-valve-surgery-a-european-perspective
#33
JOURNAL ARTICLE
Vinci Naruka, Arian Arjomandi Rad, Jacob Chacko, Guiqing Liu, Jonathan Afoke, Prakash P Punjabi
INTRODUCTION: In recent years, major findings on concomitant procedures and anticoagulation management have occurred in Mitral Valve (MV) surgery. Therefore, we sought to evaluate the current practices in MV interventions across Europe. METHODS: In October 2021, all national cardio-thoracic societies in the European region were identified following an electronic search and sent an online survey of 14 questions to distribute among their member consultant/attending cardiac surgeons...
March 2, 2024: Perfusion
https://read.qxmd.com/read/38430099/right-heart-remodeling-and-outcomes-in-patients-with-tricuspid-regurgitation-a-literature-review-and-meta-analysis
#34
JOURNAL ARTICLE
Sara Bombace, Federico Fortuni, Giacomo Viggiani, Maria Chiara Meucci, Gianluigi Condorelli, Erberto Carluccio, Maximilian von Roeder, Alexander Jobs, Holger Thiele, Giovanni Esposito, Philipp Lurz, Paul A Grayburn, Anna Sannino
BACKGROUND: Functional tricuspid regurgitation (TR) can develop either because of right ventricular (RV) remodeling (ventricular functional TR) and/or right atrial dilation (atrial functional TR). OBJECTIVES: This meta-analysis aimed to investigate the association between right heart remodeling and long-term (>1 year) all-cause mortality in patients with significant TR (at least moderate, ≥2+). METHODS: MEDLINE, ISI Web of Science, and SCOPUS databases were searched...
February 12, 2024: JACC. Cardiovascular Imaging
https://read.qxmd.com/read/38429438/a-tissue-silicone-integrated-simulator-for-right-ventricular-pulsatile-circulation-with-severe-functional-tricuspid-regurgitation
#35
JOURNAL ARTICLE
Jumpei Takada, Hayato Morimura, Kohei Hamada, Yusei Okamoto, Shiho Mineta, Yusuke Tsuboko, Kaoru Hattori, Kiyotaka Iwasaki
There is a great demand for development of a functional tricuspid regurgitation (FTR) model for accelerating development and preclinical study of tricuspid interventional repair devices. This study aimed to develop a severe FTR model by creating a tissue-silicone integrated right ventricular pulsatile circulatory simulator. The simulator incorporates the porcine tricuspid annulus, valve leaflets, chordae tendineae, papillary muscles, and right ventricular wall as one continuous piece of tissue, thereby preserving essential anatomical relationships of the tricuspid valve (TV) complex...
March 1, 2024: Scientific Reports
https://read.qxmd.com/read/38426859/transcatheter-treatment-of-the-tricuspid-valve-current-status-and-perspectives
#36
JOURNAL ARTICLE
Francesco Maisano, Rebecca Hahn, Paul Sorajja, Fabien Praz, Philipp Lurz
Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in high-risk patients with isolated or concomitant tricuspid regurgitation. The development of new minimally invasive solutions potentially more adapted to this largely undertreated population of patients, has fuelled the interest for the tricuspid valve. Growing evidence and new concepts have contributed to revise obsolete and misleading perceptions around the right side of the heart. New definitions, classifications, and a better understanding of the disease pathophysiology and phenotypes, as well as their associated patient journeys have profoundly and durably changed the landscape of tricuspid disease...
March 1, 2024: European Heart Journal
https://read.qxmd.com/read/38422528/impact-of-mitral-stenosis-on-early-and-late-outcomes-of-transcatheter-aortic-valve-replacement-for-aortic-stenosis-a-single-center-analysis
#37
JOURNAL ARTICLE
Yoshiyuki Yamashita, Serge Sicouri, Aleksander Dokollar, Mikiko Senzai, Roberto Rodriguez, Eric M Gnall, Paul M Coady, Harish Jarrett, Sandra V Abramson, Katie M Hawthorne, Scott M Goldman, William A Gray, Basel Ramlawi
OBJECTIVES: To assess the impact of concomitant mitral stenosis (MS) on early and late outcomes of transcatheter aortic valve replacement (TAVR) for aortic stenosis. METHODS: This study involved 952 patients undergoing TAVR for severe tricuspid aortic stenosis. The patients were classified into 3 groups: without MS, with progressive MS, and severe MS (mitral valve area ≤ 1.5 cm2). Clinical outcomes between these groups were compared. RESULTS: The median age of the overall cohort was 82 years, and patients in the progressive (n = 49) and severe (n = 24) MS groups were more likely to be female than those in the no-MS group (n = 879)...
February 26, 2024: Journal of Invasive Cardiology
https://read.qxmd.com/read/38422306/fibroelastoma-an-incidentaloma-disease-image-cases-of-fibroelastomas-as-incidental-findings-in-four-patients-four-different-valves
#38
JOURNAL ARTICLE
Joana Lima Lopes, Antonio Freitas, João Bicho Augusto
Fibroelastomas are the second most common benign cardiac tumor1. They are small avascular structures with a mean size of 9mm, ranging up to 70mm, usually attached to the heart valves' surface (aortic and mitral are the most affected, followed by tricuspid and pulmonary valves). Their etiology is unclear, but the hypothesis of coalescence of microthrombus at the coaptation margins of valves is the most widely accepted theory. On echocardiography, they are pedicled, mobile, with a filamentous surface, and usually have a speckled appearance with echolucencies and a stippled pattern near the edges...
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38421268/running-on-empty-factors-underpinning-impaired-cardiac-output-reserve-in-heart-failure-with-preserved-ejection-fraction
#39
REVIEW
Paula Sagmeister, Sebastian Rosch, Karl Fengler, Karl-Patrik Kresoja, Tommaso Gori, Holger Thiele, Philipp Lurz, Daniel Burkhoff, Karl-Philipp Rommel
Heart failure with preserved ejection fraction (HFpEF) is frequently attributed etiologically to an underlying left ventricular (LV) diastolic dysfunction, although its pathophysiology is far more complex and can exhibit significant variations among patients. This review endeavours to systematically unravel the pathophysiological heterogeneity by illustrating diverse mechanisms leading to an impaired cardiac output reserve, a central and prevalent haemodynamic abnormality in HFpEF patients. Drawing on previously published findings from our research group, we propose a pathophysiology-guided phenotyping based on the presence of: (1) LV diastolic dysfunction, (2) LV systolic pathologies, (3) arterial stiffness, (4) atrial impairment, (5) right ventricular dysfunction, (6) tricuspid valve regurgitation, and (7) chronotopic incompetence...
February 29, 2024: Experimental Physiology
https://read.qxmd.com/read/38420560/impact-of-tricuspid-annuloplasty-device-shape-and-size-on-valve-mechanics-a-computational-study
#40
JOURNAL ARTICLE
Collin E Haese, Mrudang Mathur, Chien-Yu Lin, Marcin Malinowski, Tomasz A Timek, Manuel K Rausch
BACKGROUND: Tricuspid valve disease significantly affects 1.6 million Americans. The gold standard treatment for tricuspid disease is the implantation of annuloplasty devices. These ring-like devices come in various shapes and sizes. Choices for both shape and size are most often made by surgical intuition rather than scientific rationale. METHODS: To understand the impact of shape and size on valve mechanics and to provide a rational basis for their selection, we used a subject-specific finite element model to conduct a virtual case study...
February 2024: JTCVS open
keyword
keyword
27158
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.